Table of Contents 2
List of Tables 6
List of Figures 6
Valeant Pharmaceuticals Intertiol, Inc. Spshot 7
Valeant Pharmaceuticals Intertiol, Inc. Overview 7
Key Information 7
Key Facts 7
Valeant Pharmaceuticals Intertiol, Inc. - Research and Development Overview 8
Key Therapeutic Areas 8
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Combition Treatment Modalities 13
Pipeline Products - Partnered Products 14
Partnered Products/Combition Treatment Modalities 15
Pipeline Products - Out-Licensed Products 16
Out-Licensed Products/Combition Treatment Modalities 17
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Products Glance 18
Valeant Pharmaceuticals Intertiol, Inc. - Late Stage Pipeline Products 18
Pre-Registration Products/Combition Treatment Modalities 18
Phase III Products/Combition Treatment Modalities 19
Valeant Pharmaceuticals Intertiol, Inc. - Clinical Stage Pipeline Products 20
Phase II Products/Combition Treatment Modalities 20
Phase I Products/Combition Treatment Modalities 21
Valeant Pharmaceuticals Intertiol, Inc. - Early Stage Pipeline Products 22
Preclinical Products/Combition Treatment Modalities 22
Valeant Pharmaceuticals Intertiol, Inc. - Unknown Stage Pipeline Products 23
Unknown Products/Combition Treatment Modalities 23
Valeant Pharmaceuticals Intertiol, Inc. - Drug Profiles 24
brodalumab 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
(halobetasol propiote + tazarotene) 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
budesonide 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
IDP-122 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
loteprednol etabote next generation 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
rifaximin DR 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
BLO-020 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
ezogabine 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
IDP-120 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
IDP-121 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
IDP-125 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
IDP-126 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
IDP-127 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
IDP-128 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
IDP-129 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
IDP-130 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
IDP-131 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
lapuleucel-T 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
ribavirin 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
SAL-021 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Product Description 51
Mechanism of Action 51
R&D Progress 51
SPT-201 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
metyrosine 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
BLO-021 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
IDP-123 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
IDP-124 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
VALBRO-03 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Alysis 58
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Products by Target 58
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Products by Route of Administration 60
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Products by Molecule Type 61
Valeant Pharmaceuticals Intertiol, Inc. - Pipeline Products by Mechanism of Action 62
Valeant Pharmaceuticals Intertiol, Inc. - Recent Pipeline Updates 64
Valeant Pharmaceuticals Intertiol, Inc. - Dormant Projects 73
Valeant Pharmaceuticals Intertiol, Inc. - Discontinued Pipeline Products 75
Discontinued Pipeline Product Profiles 75
ATON-004 75
(bupropion hydrochloride + selective serotonin reuptake inhibitor) 75
brodalumab 75
CVTE-002 76
ezogabine 76
IDP-107 76
IDP-109 76
IDP-115 76
MC-5 76
methylltrexone bromide 76
pegaptanib sodium 76
rifaximin 76
RUS-350 77
taribavirin hydrochloride 77
tiazofurin 77
UK-279276 77
Valeant Pharmaceuticals Intertiol, Inc. - Company Statement 78
Valeant Pharmaceuticals Intertiol, Inc. - Locations And Subsidiaries 81
Head Office 81
Other Locations & Subsidiaries 81
Appendix 89
Methodology 89
Coverage 89
Secondary Research 89
Primary Research 89
Expert Panel Validation 89
Contact Us 89
Disclaimer 90